Principal Investigator

Prof. Dr. Maria C. Katapodi
University of Basel
» Profil on dkf.unibas.ch

University of Basel
More Information

Prof. Katapodi has more than 15 years experience caring for women affected by breast cancer and their families. She is interested in how women make decisions about genetic testing and cancer screening, how family members cope with hereditary cancer, and in increasing public awareness about use of genetic counseling and testing.

Scientific Collaborators

Monica Aceti

Monica Aceti
University of Basel

University of Basel
More Information

Monica Aceti is a social anthropologist and research associate in the CASCADE and DIALOGUE study at the Department of Clinical Research of the Faculty of Medicine at the University of Basel. She is interested in the logic of communication between patients and their relatives. Previously, she coordinated a research program through citizens’ forums on hopes and fears in precision oncology at the Institute for Sociological Research (IRS) of the University of Geneva.

Vasiliki Baroutsou

Vasiliki Baroutsou
University of Basel

University of Basel
More Information

Vasiliki Baroutsou is a PhD candidate in Clinical Research at the Faculty of Medicine at the University of Basel. She has been mainly involved in conducting and designing clinical studies. Her recent research focusses on the implementation of digital health interventions among breast cancer carriers and their families. Vasiliki holds a master degree in International Public Health from Liverpool School of Tropical Medicine (LSTM) in UK.

PD Dr. med. Nicole Bürki

PD Dr. med. Nicole Bürki
University Hospital Basel (USB)

University Hospital Basel (USB)
More Information

Nicole Bürki is in charge of the “Genetic counseling for familial breast and ovarian cancer” at the University Hospital in Basel since June 2013. She is an active member of the “Network for Cancer Predisposition Testing and Counseling” of the Swiss Group for Clinical Cancer Research (SAKK) and the SAKK Breast Cancer Group.

Prof. Dr. Maria Caiata Zufferey

Prof. Dr. Maria Caiata Zufferey
University of Applied Sciences and Arts of Southern Switzerland (SUPSI)

SUPSI
More Information

Maria Caiata-Zufferey is Professor in Qualitative Research in the Social and Health Sciences at the Department of Business Economics, Health and Social Care (DEASS) of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI), where she is also head of the Competence Center for Healthcare Practices and Policies. Maria Caiata-Zufferey holds a PhD in social sciences from the University of Fribourg, Switzerland. In the field of genetics, she is particularly interested in how women manage the uncertainty related to their genetic predisposition to develop breast and ovarian cancer, and in the role of communication in this situation.

Prof. Dr. Pierre O. Chappuis, MD

Prof. Dr. Pierre O. Chappuis, MD
Hôpitaux Universitaire Genève (HUG)

HÔPITAUX UNIVERSITAIRES GENÈVE
More Information

Pierre Chappuis is onco-geneticist and responsible for the Breast Center at the Hôpitaux Universitaire Genève (HUG), Switzerland. Pierre Chappuis currently manages the HUG Breast Center, which opened in 2011 and since 2014 benefits from the quality label assigned to it by the Swiss Cancer League and the Swiss Senology Society. Furthermore, he is responsible for the oncogenetics program at the hospital, which focuses on onco-genetic consultations and a multidisciplinary consensus.

Tobias Erlanger

Dr. Tobias Erlanger
University Hospital Basel (USB)

University Hospital Basel (USB)
More Information

Tobias Erlanger has an MSc in Biology and a PhD in Epidemiology. He is a clinical epidemiologist at the Department of Clinical Research, University Hospital Basel. His research during the MSc and PhD programme 2002 – 2007 at the Swiss Tropical & Public Health Institute focussed on causes and preventive measures of the transmission of infectious diseases in Tansania and Laos. He then continued his career in the pharmaceutical industry. Among other domains, he was active in medical affairs, health technology assessment, outcomes research, and meta-analysis. After that, he moved to the Department of Health of the Canton of Basel-Stadt. He built a monitoring system for the newly introduced disease-related groups (DRG) for in-patient accounting. After returning to academic research in health information technology in Canada and primary health care in Switzerland, he settled down at the Clinical Trial Unit in 2016. Currently, his work is centered around methodological issues of RCTs and the design and analyses of studies in various areas of health and medicine.

Muriel Fluri

Muriel Fluri
University Hospital of Bern (Inselspital)

University Hospital of Bern (Inselspital)
More Information

Muriel works as an Advanced Practice Nurse in genetic counselling at the Clinic of Medical Oncology, University Hospital of Bern, Inselspital and as a research assistant for the CASCADE study at the Department of Clinical Research, Faculty of Medicine at the University of Basel. Muriel Fluri holds a Master of Science degree in Nursing from the University of Applied Sciences Bern. She is interested in how people with a confirmed predisposition can be better cared for by an Advanced Practice Nurse.

Dr. med. Rosella Graffeo

Dr. med. Rossella Graffeo
Istituto Oncologico della Svizzera Italiana (IOSI)

Ente Ospedaliero Cantonale
More Information

Rossella Graffeo is a senior medical oncologist at the Istituto Oncologico della Svizzera Italiana (IOSI) and director of the oncogenetics service at the division of medical genetics. Her main clinical and research interests focus on breast cancer and genetic risk evaluation in young women.

Prof. Dr. med. Dr. phil Karl Heinimann, MD, PhD

Prof. Dr. med. Dr. phil Karl Heinimann
University Hospital Basel (USB)

University Hospital Basel (USB)
More Information

Karl Heinimann is a Professor of Medical Genetics at the University Hospital in Basel and the Department of Biomedicine at the University of Basel, Switzerland.

Prof. Dr. Viola Heinzelmann-Schwarz

Prof. Dr. Viola Heinzelmann-Schwarz
University Hospital Basel (USB)

University Hospital Basel (USB)
More Information

Viola Heinzelmann-Schwarz is a specialist in gynecology and obstetrics, a subspecialist in gynecological oncology and the overall director of the gynecological clinic at the University Hospital Basel. After study visits in Tübingen, London (UCL), Dunedin / New Zealand and Zurich, Viola Heinzelmann-Schwarz completed her training as a gynecologist at the University Hospital of Zurich. She received her Venia Legendi (Privatdozentin) at the University of Zurich in 2007. From 2008 to 2012 she was sub-specialized in one of Australia’s largest gynecological cancer centers in Sydney. Her clinical and scientific focus is on gynecological carcinomas, especially ovarian cancer.

Dr. des. Andrea Kaiser-Grolimund

Dr. des. Andrea Kaiser-Grolimund
University of Basel

University of Basel
More Information

Andrea Kaiser-Grolimund is social anthropologist working at the Institute of Nursing Science at the Faculty of Medicine at the University of Basel. Andrea Kaiser-Grolimund holds a PhD in Social Anthropology from University of Basel and she is interested in care relations in private settings.

Helen Koechlin

Dr. Helen Koechlin
University of Basel

University of Basel
More Information

Helen Koechlin is a post-doctoral researcher at the Division of Clinical Psychology and Psychotherapy, Faculty of Psychology at the University of Basel, and affiliated with the Department of Anesthesiology, Critical Care and Pain Medicine at Boston Children’s Hospital, Harvard Medical School. She holds a PhD in Psychology from the University of Basel and her research is concerned with several topics within the field of child and adolescent psychology, among them the well-being of children of critically ill parents.

PD Dr. Christian Kurzeder, PhD

PD Dr. Christian Kurzeder, PhD
University Hospital Basel (USB)

University Hospital Basel (USB)
More Information

Christian Kurzeder is the leader of the Breast Center, Head Physician of Senology and Deputy Head Physician of Gynaecologic Oncology at the University Hospital in Basel, Switzerland. Christian Kurzeder is member of the PHB Oncology Cluster, which has the goal to create a multidisciplinary center for translational research in Personalized Health medicine in the cancer field. In the most recent papers that he co-authored, he focuses amongst others on oncoplastic breast conserving surgery in connection to the treatment of breast cancer.

Dr. Christian Monnerat

Dr. Christian Monnerat
Hôpital du Jura

Hôpital du Jura
More Information

Christian Monnerat is the head physician of the Oncology Unit of the Hôpital du Jura, where he also provides oncogenetic consultations. In 1997, Christian Monnerat obtained his FMH title of Internal Medicine and his doctorate in medicine in 1998 with the Prize of the Faculty of Medicine of Lausanne. In 1999, he obtained his FMH title of medical oncology. In 2001, he won the European University Diploma in Clinical Research in Cancerology from the University of Paris XI and the Institut Gustave-Roussy, as well as the Master of Genetics with mention of the University of Paris V and the Hôpital Necker-Enfants malades.

Prof. Dr. Olivia Pagani

Prof. Dr. Olivia Pagani
Centro di Consulenza Genetica Oncologica della Svizzera Italiana (CCGO)

Ente Ospedaliero Cantonale
More Information

Olivia Pagani, has been, till 2018, the director of the Centro di Senologia della Svizzera Italiana, a certified centre at European and Swiss level. She is responsible of the Centro di Consulenza Genetica Oncologica della Svizzera Italiana (CCGO) and head deputy at the Istituto Oncologico della Svizzera Italiana (IOSI). Olivia Pagani’s main clinical and research interests are breast cancer in young women and advanced breast cancer.

Carla Pedrazzani

Carla Pedrazzani
University of Basel

University of Basel
More Information

Carla Pedrazzani is a PhD candidate in Nursing Science at the Faculty of Medicine at the University of Basel as well as lecturer and researcher at the Department of Business Economics, Health and Social Care (DEASS) of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI). Carla Pedrazzani holds a Master of Science degree in Nursing from University of Turin, Italy. She is interested in oncology nursing, in communication in hereditary cancers and in genetic nursing practice.

Prof. Dr. Nicole Probst-Hensch, MPH

Prof. Dr. Nicole Probst-Hensch, MPH
Swiss Tropical and Public Health Institute (Swiss TPH)

Swiss Tropical and Public Health Institute (Swiss TPH)
More Information

Nicole Probst-Hensch is the Head of the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute (Swiss TPH) and Professor in Epidemiology and Public Health at the Medical Faculty of the University of Basel, Switzerland. Nicole Probst-Hensch holds doctorates in pharmaceutical sciences and in epidemiology. After she had been appointed Assistant Professor at USC/Norris Comprehensive Cancer Center in Los Angeles she came back to the Unversity of Zürich, where she achieved her habilitation in 2004. In Switzerland, she established the National Institute of Cancer Epidemiology and Registration (NICER), as its first director. At Swiss TPH, Nicole Probst-Hensch is responsible for the group working on Genetic Epidemiology of Non-Communicable Diseases. 

Dr. med. Manuela Rabaglio

Dr. med. Manuela Rabaglio
University Hospital of Bern (Inselspital)

University Hospital of Bern (Inselspital)
More Information

Manuela Rabaglio is senior registrar at the Clinic of Medical Oncology, University Hospital of Bern, Inselspital where she is also head of the Quality Assurance Clinical Trial Unit. Manuela Rabaglio is the head of medical affairs at IBCSG, Bern and she received her professional qualifications in Switzerland and Portugal. Her current focus lies on genetic counseling and cancer prevention for breast cancer, gynecological tumors and other hereditary cancer syndromes.

Marion Rudaz

Marion Rudaz
University of Basel

University of Basel
More Information

Marion Rudaz works for the CASCADE study at the Department of Clinical Research at the Faculty of Medicine at the University of Basel. She obtained a Master of Science in Psychology from the University of Basel and is interested in how breast cancer survivors and their relatives influence each other in terms of psychological and physiological factors.

Yu-Yin Su Allemann

Yu-Yin Su Allemann
University of Basel

University of Basel
More Information

Yu-Yin Su-Alleman is a research associate at the Institute of Nursing Science at the Faculty of Medicine at the University of Basel. Yu-Yin holds a MA degree in Nursing Sciences from University of Illinois at Chicago (UIC), her main interests in research are symptom clusters and symptom management among breast cancer survivors.

Dr. Monica Taborelli

Dr. Monica Taborelli
Centro di Consulenza Genetica Oncologica della Svizzera Italiana (CCGO)

Ente Ospedaliero Cantonale
More Information

Monica Taborelli is currently working as a clinical geneticist at the Centro di Consulenza Genetica Oncologica della Svizzera Italiana (CCGO) at the Istituto Oncologico della Svizzera Italiana (IOSI).  She is also one of the organizers of the ESO-ESMO breast cancer in young women international conference that takes place on a yearly base in the southern part of Switzerland.

Dr. Valeria Viassolo

Dr. Valeria Viassolo
Hôpitaux Universitaire Genève (HUG)

HÔPITAUX UNIVERSITAIRES GENÈVE
More Information

Valeria Viassolo is Onco-geneticist at the Hôpitaux Universitaire Genève (HUG), Switzerland. In 2003, Valeria Viassolo received her medical degree at the Faculty of Medicine and Surgery at the University of Genova in Italy. In her post-grade studies at the same faculty she specialized in medical genetics and wrote her thesis on hereditary breast and ovarian cancer. Valeria Viassolo came to the HUG in 2012. She is member of the Network for Cancer Predisposition Testing and Counseling of the Swiss Group for Clinical Cancer Research (SAKK) and focuses in her activities as a clinician as well as in her clinical and translational research on genetic predispositions of cancer.